The Identification of Molecular Subtypes of Gastric Cancer

Publication
Article
Special ReportsGastrointestinal Cancers (Issue 1)
Volume 1
Issue 1

Pamela L. Kunz, MD, assistant professor of medicine, Oncology, Stanford University Medical Center, discusses the need to identify molecular subtypes of gastric cancer.

Pamela L. Kunz, MD, assistant professor of medicine, Oncology, Stanford University Medical Center, discusses the need to identify molecular subtypes of gastric cancer.

Learn more aboutthe treatment of gastric cancer > >

Articles in this issue
The Identification of Molecular Subtypes of Gastric Cancer
The Identification of Molecular Subtypes of Gastric Cancer
Ramucirumab Combo Increases Survival in Gastric Cancer
Ramucirumab Combo Increases Survival in Gastric Cancer
<em>RAS</em> Status Matters in mCRC: Confirmed by Second-Line Data
<em>RAS</em> Status Matters in mCRC: Confirmed by Second-Line Data
New Standard of Neoadjuvant Care for Rectal Cancer Established
New Standard of Neoadjuvant Care for Rectal Cancer Established
Reducing the Risk of Relapse in Patients With Pancreatic Cancer
Reducing the Risk of Relapse in Patients With Pancreatic Cancer
Vismodegib Demonstrates Activity in Advanced Pancreatic Cancer
Vismodegib Demonstrates Activity in Advanced Pancreatic Cancer
The Treatment of Advanced Colorectal Cancer
The Treatment of Advanced Colorectal Cancer
Studies Emphasize Need for Full <em>RAS</em> Mutational Analyses in the Management of mCRC
Studies Emphasize Need for Full <em>RAS</em> Mutational Analyses in the Management of mCRC
TTP, OS Benefit Seen Following Treatment With TGF-β Inhibitor in HCC
TTP, OS Benefit Seen Following Treatment With TGF-β Inhibitor in HCC

Newsletter

Stay up to date on practice-changing data in community practice.

Subscribe Now!
Recent Videos
Targeted Therapy Options for Gastric/GEJ Cancers Expand
Targeted Therapy Options for Gastric/GEJ Cancers Expand
David Zhen, MD, an expert on gastric cancer
The Future of Upper Gastric Cancer Treatment
David Zhen, MD, an expert on gastric cancer
Ongoing Research in Upper Gastric Cancer
David Zhen, MD, an expert on gastric cancer
Second-Line Treatment of Gastric Adenocarcinoma
David Zhen, MD, an expert on gastric cancer
Managing Adverse Events from Immunotherapy in Upper Gastric Cancer
David Zhen, MD, an expert on gastric cancer
The Role of Immunotherapies in Upper GI Cancers
David Zhen, MD, an expert on gastric cancer
Frontline Treatment Options for Gastric Adenocarcinoma
David Zhen, MD, an expert on gastric cancer
Patient Profile: A 60-Year-Old Man with Stage IV Gastric Adenocarcinoma
Closing Thoughts on Recent Data in GI Cancers From ESMO 2023
Closing Thoughts on Recent Data in GI Cancers From ESMO 2023
GASTFOX: Evaluate FOLFOX With or Without Docetaxel (TFOX) as First-Line Chemotherapy for Locally Advanced or Metastatic Esophago-Gastric Carcinoma
GASTFOX: Evaluate FOLFOX With or Without Docetaxel (TFOX) as First-Line Chemotherapy for Locally Advanced or Metastatic Esophago-Gastric Carcinoma
Related Content
Targeting FRα and B7-H4 in Endometrial Cancer

Targeting FRα and B7-H4 in Endometrial Cancer

Jax DiEugenio
April 9th 2025
Article

A retrospective study showed that either folate receptor alpha or B7-H4 was expressed in more than 80% of endometrial cancers evaluated.

Read More

FDA Approves Nivolumab/Ipilimumab Combo in MSI-H/dMMR mCRC

FDA Approves Nivolumab/Ipilimumab Combo in MSI-H/dMMR mCRC

Jordyn Sava
April 8th 2025
Article

Based on data from the phase 3 CheckMate-8HW trial, the combination of nivolumab and ipilimumab has been approved by the FDA in metastatic colorectal cancer.

Read More

Americans’ Frustration With The Health Care Industry Builds

Americans’ Frustration With The Health Care Industry Builds

Lindsay Dymowski Constantino
April 8th 2025
Article

Read More

HIF-2α Inhibitors Make Significant Inroads in Renal Cell Carcinoma

HIF-2α Inhibitors Make Significant Inroads in Renal Cell Carcinoma

Tony Berberabe, MPH
April 7th 2025
Article

Read More

Insights from ASCO GI and the Future of CAR T-Cell Therapy in Solid Tumors

Insights from ASCO GI and the Future of CAR T-Cell Therapy in Solid Tumors

Robert L. Ferris, MD, PhD
April 4th 2025
Article

The GI Cancers Symposium revealed new therapies for specific cancer subsets and progress in chimeric antigen receptor T-cell therapies for solid tumors.

Read More

Survivorship Care Promotes Evidence-Based Approaches for Quality of Life and Beyond

Survivorship Care Promotes Evidence-Based Approaches for Quality of Life and Beyond

Jonah Feldman
March 21st 2025
Article

Frank J. Penedo, PhD, explains the challenges of survivorship care for patients with cancer and how he implements programs to support patients’ emotional, physical, and practical needs.

Read More